Clinical trial
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing…
NCT00170729 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00170729 |
|---|---|
| Title | A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery |
| Official title | Multi-center, Randomized, Double Masked, Vehicle Controlled Phase IV Study to Compare the Efficacy, Ocular Safety and Tolerability of a Two Day Treatment With Eye Drops (0.5% Prednisolone Acetate, One Drop Four Times Per Day) in Patients With Intraocular Inflammation After Cataract Surgery, Followed… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cataract Surgery |
| Intervention type | Drug |
| Interventions | Prednisolone acetate |
| Enrollment | 62 |
| Start date | Aug 17, 2004 |
| Primary completion | Feb 28, 2005 |
| Completion | Feb 28, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 1, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: